Mechanism of action
Povidone-iodine is an iodophor, a chemical complex that slowly releases free molecular iodine (I₂) when in contact with tissue or microorganisms. The polyvinylpyrrolidone (povidone) carrier acts as a reservoir and controlled-release vehicle, reducing the irritation associated with elemental iodine while maintaining antimicrobial efficacy.
Free iodine rapidly penetrates microbial cell walls and membranes. Once inside, it oxidizes and iodinates amino acids, nucleotides, and fatty acids, leading to disruption of protein synthesis, enzyme inactivation, and destabilization of cell membranes. This multisite mechanism results in rapid microbial death.
Antimicrobial spectrum
Povidone-iodine demonstrates broad-spectrum activity:
- Bacteria: Gram-positive and gram-negative organisms, including MRSA and VRE
- Mycobacteria: Including Mycobacterium tuberculosis
- Viruses: Enveloped and non-enveloped viruses (HIV, HSV, influenza, SARS-CoV-2)
- Fungi: Yeasts and molds, including Candida species
- Protozoa: Including Giardia and Entamoeba
- Spores: Sporicidal at higher concentrations and contact times
Microbial resistance to iodine is extremely rare due to its multi-target mechanism. Antiseptic activity begins within 15-30 seconds of application, with maximal effect at 1-2 minutes. The sustained-release formulation maintains antimicrobial activity for several hours after application.
- Povidone-iodine releases free iodine that denatures microbial proteins and nucleic acids, providing broad-spectrum antimicrobial activity including bacteria, viruses, fungi, and spores.
- Microbial resistance to iodine is extremely rare due to its multi-target mechanism of action.
- Systemic iodine absorption can cause thyroid dysfunction (hypothyroidism via Wolff-Chaikoff effect or hyperthyroidism via Jod-Basedow phenomenon), especially in neonates, pregnancy, and with large surface area or prolonged use.
- Shellfish and radiocontrast allergies are NOT contraindications to povidone-iodine use; true iodine allergy is extremely rare.
- Povidone-iodine interferes with radioactive iodine uptake and thyroid function tests for days to weeks after use.
- Contact time of 1-2 minutes is required for optimal antimicrobial effect; immediate wiping reduces efficacy.
- Use cautiously in neonates due to increased percutaneous absorption and risk of hypothyroidism; avoid under occlusive dressings.
- Alcohol-based formulations are flammable; ensure complete drying and prevent pooling before electrocautery to avoid surgical fires.
Indications
Povidone-iodine is approved for multiple topical antiseptic applications across various medical and surgical settings.
Surgical and procedural use
- Preoperative skin preparation: Reduces skin microbial flora before incision
- Surgical scrub: For healthcare workers' hand and forearm antisepsis
- Catheter site care: Central venous and urinary catheter insertion sites
- Injection site disinfection: Before venipuncture or injections
Wound care
- Acute traumatic wounds: Irrigation and cleaning of lacerations, abrasions
- Burn wounds: Topical application to prevent infection (lower concentrations)
- Chronic wounds: Ulcers, pressure sores (used cautiously)
- Umbilical cord care: In neonates to prevent omphalitis
Mucosal applications
- Oral antisepsis: Mouthwashes and gargles for pharyngitis, gingivitis, oral surgery
- Vaginal antisepsis: Treatment of vaginitis and preoperative preparation
- Ophthalmic use: Prophylaxis before ocular surgery (dilute solutions)
Other indications
- Water purification: Emergency disinfection of drinking water
- Superficial skin infections: Impetigo, folliculitis (adjunctive)
Dosing and application duration follow product-specific guidelines and vary by indication, concentration (typically 7.5-10%), and formulation (solution, scrub, ointment, swabstick).
Pharmacokinetics
Povidone-iodine is intended for topical use only, and its pharmacokinetics primarily involve local release of iodine with variable systemic absorption depending on application site, concentration, duration, and skin integrity.
Absorption
Systemic absorption of iodine occurs through intact skin, but is significantly increased through:
- Mucous membranes (oral, vaginal)
- Damaged or denuded skin (burns, wounds)
- Large surface area applications
- Prolonged or repeated use
- Occlusive dressings
Neonates and infants have increased percutaneous absorption due to higher skin permeability and body surface area-to-weight ratio.
Distribution
Absorbed iodine distributes throughout body fluids and concentrates in the thyroid gland. It crosses the placenta and is excreted in breast milk.
Metabolism and excretion
Iodine absorbed systemically is primarily eliminated by the kidneys. The thyroid gland actively traps iodine for hormone synthesis. Renal impairment may prolong iodine elimination and increase risk of accumulation.
Clinical implications
Systemic iodine absorption can interfere with:
- Thyroid function tests: Elevates protein-bound iodine, may suppress radioactive iodine uptake for weeks
- Thyroid function: Can cause hypothyroidism or hyperthyroidism, especially with chronic use
- Neonatal screening: May cause false-positive results for congenital hypothyroidism
Monitoring of thyroid function is recommended with prolonged use, large surface area applications, or in at-risk populations (neonates, pregnant women, patients with thyroid disease).
Adverse effects
Povidone-iodine is generally well-tolerated for short-term topical use, but adverse effects can occur, particularly with prolonged application, large surface areas, or in vulnerable populations.
Local reactions
- Contact dermatitis: Most common adverse effect; irritant or allergic type
- Skin irritation: Burning, stinging, erythema at application site
- Delayed wound healing: Cytotoxic to fibroblasts and keratinocytes in vitro (clinical significance debated)
- Discoloration: Brown staining of skin, mucosa, and clothing
- Chemical burns: Rare, with prolonged contact or occlusion
Systemic effects
Thyroid dysfunction (with significant absorption):
- Hypothyroidism: More common; from Wolff-Chaikoff effect (iodine-induced suppression of thyroid hormone synthesis)
- Hyperthyroidism: Jod-Basedow phenomenon in iodine-deficient individuals or those with autonomous thyroid nodules
- Goiter: Especially in neonates with prolonged exposure
Metabolic effects:
- Metabolic acidosis (with large surface area burns)
- Hypernatremia and hyperchloremia
- Acute kidney injury (rare)
Hypersensitivity reactions
- True iodine allergy is rare but can occur
- Anaphylaxis is extremely rare
- Cross-reactivity with shellfish allergy is a myth (shellfish allergy is to tropomyosin protein, not iodine)
- Radiocontrast reactions are due to contrast agent structure, not iodine content
Special populations
Neonates: Increased risk of hypothyroidism, especially premature infants and with umbilical cord applications.
Pregnancy: Fetal thyroid suppression possible with chronic maternal exposure.
Breastfeeding: Iodine excreted in milk may affect infant thyroid function with maternal chronic use.
Adverse effects are minimized by using the lowest effective concentration for the shortest duration necessary.
Contraindications and warnings
Absolute contraindications
- Known hypersensitivity to povidone-iodine or iodine
- Dermatitis herpetiformis (Duhring's disease; iodine triggers severe flares)
- Manifest hyperthyroidism (risk of exacerbating thyrotoxicosis)
- Use in or around the eye (except dilute ophthalmic formulations)
- Application before radioactive iodine therapy (interferes with treatment)
Relative contraindications and warnings
Thyroid disease:
- Use cautiously in patients with Hashimoto thyroiditis or other thyroid disorders
- Avoid chronic use in patients with nodular goiter or hyperthyroidism risk
- Monitor thyroid function with prolonged use
Renal impairment:
- Reduced iodine clearance increases systemic accumulation risk
- Avoid large surface area applications in severe renal disease
Neonates and infants:
- Avoid routine use on large areas
- Do not use under occlusive dressings
- Monitor for hypothyroidism with repeated applications
- Vaginal use during delivery may affect neonatal thyroid screening
Pregnancy and lactation:
- Pregnancy Category D (FDA classification, now historical): fetal thyroid suppression possible
- Use only when clearly needed and benefit outweighs risk
- Avoid prolonged or extensive application
- Breastfeeding: minimize use; monitor infant for hypothyroidism symptoms with chronic maternal use
Burns and large wounds:
- Significant systemic absorption possible
- Risk of metabolic acidosis, renal toxicity
- Consider alternative antiseptics for chronic wound management
Surgical considerations:
- Alcohol-based formulations are flammable; allow complete drying before electrocautery or laser use
- Do not pool under patient or in body folds (fire and chemical burn risk)
- Protect eyes during head and neck procedures
Drug-specific warnings
- Do not use in body cavities (peritoneal, pleural) except ophthalmic formulations in the eye
- Avoid concurrent use with mercury-containing antiseptics (corrosive iodide formation)
- Not for injection or ingestion (except dilute oral rinse formulations)
Drug interactions
Povidone-iodine has few systemic drug interactions due to its primarily topical action, but important interactions exist with concurrent topical agents, thyroid medications, and diagnostic procedures.
Topical agent interactions
Antiseptics and disinfectants:
- Hydrogen peroxide: Mutual inactivation; avoid simultaneous application
- Silver sulfadiazine: Iodine inactivates silver; do not combine
- Enzymatic debriding agents: Iodine may inactivate proteolytic enzymes
- Mercurial antiseptics: Form corrosive compounds; never mix
Topical antibiotics: Povidone-iodine may reduce effectiveness; apply separately if both needed.
Systemic interactions
Lithium:
- Additive hypothyroid effects with chronic iodine absorption
- Monitor thyroid function if both used chronically
Antithyroid drugs (methimazole, propylthiouracil):
- Additive hypothyroid effects
- Iodine absorption may complicate management of hyperthyroidism
Thyroid hormones (levothyroxine, liothyronine):
- Iodine-induced hypothyroidism may increase thyroid hormone requirements
Diagnostic test interference
Thyroid function tests:
- Elevates serum inorganic iodine levels
- Suppresses radioactive iodine uptake (RAIU) for days to weeks
- May cause transient TSH elevation
- Can interfere with thyroid scans and radioiodine treatment
Neonatal screening:
- Maternal or neonatal exposure may cause false-positive hypothyroidism screening
Stool tests:
- May cause false-positive guaiac-based fecal occult blood tests
Other laboratory tests:
- Interferes with some urine and serum chemistry tests if significant absorption occurs
Clinical recommendations
- Separate application of incompatible topical agents by several hours
- Inform laboratory and nuclear medicine staff of povidone-iodine use
- Delay radioiodine procedures until urinary iodine levels normalize (typically several weeks)
- Consider alternative antiseptics in patients requiring imminent thyroid imaging or radioiodine therapy
Clinical pearls
- Contact time matters: Antimicrobial activity requires adequate contact time (1-2 minutes for surgical prep). Wiping away immediately reduces efficacy.
- Dilution paradox: Very dilute povidone-iodine (0.1-1%) may have greater antimicrobial activity than concentrated solutions because more free iodine is immediately available. However, concentrated solutions provide sustained activity.
- Not just for bacteria: Unlike many topical antibiotics, povidone-iodine is virucidal, fungicidal, and sporicidal, making it valuable when the causative organism is unknown.
- Color as an indicator: The brown color indicates available iodine. When the solution becomes colorless or pale yellow, antimicrobial activity is depleted.
- Shellfish allergy myth: Patients with shellfish or contrast dye allergies are NOT allergic to iodine and can safely use povidone-iodine. Allergic reactions to povidone-iodine are typically to the povidone carrier, not iodine.
- Wound healing controversy: While cytotoxic to cells in vitro, clinical evidence for delayed wound healing is mixed. Brief use for initial wound cleansing is generally considered safe; prolonged application to healing wounds is discouraged.
- Fire safety: Alcohol-based povidone-iodine preparations are flammable. Allow complete drying and prevent pooling before using electrocautery, especially in oxygen-enriched environments.
- Thyroid monitoring: Check baseline and periodic TSH in neonates, pregnant women, and patients receiving chronic or large-area applications.
- Resistance is rare: Unlike antibiotics, clinically significant microbial resistance to iodine does not develop, making it reliable for infection prevention even in settings with multidrug-resistant organisms.
- Neonatal use caution: The FDA issued a warning about iodine-containing antiseptics in infants <32 weeks gestational age due to hypothyroidism risk. Use the minimum necessary and avoid occlusion.
- Acidic pH: Povidone-iodine solutions are acidic (pH 3-5), which contributes to antimicrobial activity but may cause stinging on broken skin or mucosa.
- Ophthalmic use: Only specially formulated dilute ophthalmic povidone-iodine (typically 5%) should be used in or around the eye. Standard surgical scrub formulations contain detergents that damage the cornea.
I-O-DINE for povidone-iodine toxicity: Iodine absorption, Overuse risk, Don't use in infants excessively, Interferes with thyroid tests, Neonatal hypothyroidism, Elevated TSH possible.
Practice questions
1. A 2-day-old neonate born at 30 weeks gestation develops lethargy and poor feeding. The umbilical cord was treated with povidone-iodine solution twice daily since birth. Vital signs are stable. Physical examination shows an enlarged tongue and umbilical hernia. Laboratory studies show TSH 45 mIU/L (normal 0.5-6) and free T4 0.4 ng/dL (normal 0.8-2.0). Which of the following best explains this patient's condition?
2. A 55-year-old woman with a history of multinodular goiter presents to the emergency department with palpitations, tremor, and heat intolerance for 2 weeks. She underwent hip replacement surgery 3 weeks ago with extensive povidone-iodine skin preparation. Vital signs show heart rate 118/min and blood pressure 148/88 mm Hg. Thyroid examination reveals multiple nodules without tenderness. Laboratory studies show TSH 0.05 mIU/L (normal 0.5-5), free T4 3.8 ng/dL (normal 0.8-2), and total T3 320 ng/dL (normal 80-200). Which mechanism best explains her thyrotoxicosis?
3. A surgical team is preparing for an elective laparoscopic cholecystectomy. After applying povidone-iodine solution to the patient's abdomen, the surgeon immediately drapes the patient and begins the procedure with electrocautery. During initial incision, a flame ignites on the surgical drapes. The patient sustains a superficial burn. Which of the following is the most likely contributing factor to this complication?
Frequently asked questions
How does povidone-iodine work?
Povidone-iodine works by slowly releasing free molecular iodine, which penetrates microbial cell walls and oxidizes proteins, nucleotides, and lipids, leading to cell death. The polyvinylpyrrolidone carrier acts as a reservoir for controlled iodine release, reducing tissue irritation while maintaining broad-spectrum antimicrobial activity against bacteria, viruses, fungi, protozoa, and spores. This multi-target mechanism prevents development of resistance and provides rapid microbicidal action within 1-2 minutes of contact.
What are the side effects of povidone-iodine?
The most common side effect is local skin irritation or contact dermatitis at the application site. With significant systemic absorption (large surface areas, prolonged use, or broken skin), povidone-iodine can cause thyroid dysfunction including hypothyroidism (more common) or hyperthyroidism, particularly in neonates, pregnant women, and those with pre-existing thyroid disease. It interferes with thyroid function tests and radioactive iodine uptake. Rare adverse effects include metabolic acidosis with extensive burn applications and chemical burns with prolonged occlusive contact.
Can you use povidone-iodine if allergic to shellfish?
Yes, shellfish allergy is not a contraindication to povidone-iodine use. Shellfish allergies are caused by tropomyosin proteins, not iodine. Similarly, radiocontrast dye reactions are due to the contrast molecule structure, not iodine content. True allergy to elemental iodine is extremely rare. Adverse reactions to povidone-iodine are usually due to the povidone carrier or represent irritant contact dermatitis rather than true allergy. Patients with shellfish or contrast allergies can safely use povidone-iodine for wound care and surgical preparation.
Is povidone-iodine safe during pregnancy?
Povidone-iodine should be used cautiously and only when necessary during pregnancy. It was classified as FDA Pregnancy Category D due to risk of fetal thyroid suppression from maternal iodine absorption. Brief, limited-area applications (such as single surgical site preparation) are generally considered low risk, but prolonged use, large surface area applications, or repeated use should be avoided. Absorbed iodine crosses the placenta and can affect fetal thyroid development. If use is necessary, the minimum effective amount should be applied for the shortest duration, and alternative antiseptics should be considered when possible.
Povidone-iodine vs chlorhexidine — what is the difference?
Povidone-iodine and chlorhexidine are both broad-spectrum antiseptics but differ in key ways. Povidone-iodine acts faster (1-2 minutes vs 2-5 minutes) and has broader antimicrobial coverage including sporicidal activity and better virucidal efficacy. Chlorhexidine provides longer residual activity (up to 6 hours) due to binding to skin proteins, while povidone-iodine's effect diminishes as iodine is depleted. Chlorhexidine is less affected by organic matter and causes less thyroid toxicity, making it preferred for prolonged or repeated use. Povidone-iodine is generally less expensive and has no resistance development. For surgical site preparation, both are effective; choice depends on specific clinical scenario, patient factors, and institutional protocols.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: D08AG02WHO ATC/DDD index: D09AA09
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.